Answers are grounded in this paper and cite their sources.
This Guide to Statistics and Methods summarizes the key characteristics, strengths, and limitations of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) reporting guidelines for comparative effectiveness research studies using nonrandomized, secondary data sources.
No takes yet. Share an insight, caveat, or question.
Massarweh et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: